Health Canada drug identification number

DIN 00868965 — SUPRAX 100 MG

SUPRAX is a powder for suspension of Cefixime marketed by ODAN LABORATORIESLTD. The full Cefixime monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
00868965
Brand name
SUPRAX
Active ingredient
Cefixime
Strength
100 MG
Dosage form
POWDER FOR SUSPENSION
Route
ORAL
Manufacturer
ODAN LABORATORIESLTD
Health Canada status
MARKETED
Drug class
Third-generation cephalosporin antibiotic

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Other Cefixime products

DINBrandStrengthFormManufacturerStatus
02468689 AURO-CEFIXIME 100 MG POWDER FOR SUSPENSION AURO PHARMA INC MARKETED
02432773 AURO-CEFIXIME 400 MG TABLET AURO PHARMA INC MARKETED
00868981 SUPRAX 400 MG TABLET ODAN LABORATORIESLTD MARKETED

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.